Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian J Taylor

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Blood|June 26, 2008
Analysis of clonotypic switch junctions reveals multiple myeloma originates from a single class switch event with ongoing mutation in the isotype-switched progenyBrian J Taylor, Jitra Kriangkum, Julie A Pittman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Molecular characterization of Waldenstrom's macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequencesJitra Kriangkum, Brian J Taylor, Steven P Treon, et al.
The American Journal of Tropical Medicine and Hygiene|July 20, 2017
A Direct from Blood Reverse Transcriptase Polymerase Chain Reaction Assay for Monitoring Falciparum Malaria Parasite Transmission in Elimination SettingsBrian J Taylor, Kjerstin Lanke, Shanna L Banman, et al.
Blood|October 24, 2002
In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expressionJonathan J Keats, Tony Reiman, Christopher A Maxwell, et al.
The Journal of Cardiovascular Nursing|May 5, 2018
Patient and Professional Factors That Impact the Perceived Likelihood and Confidence of Healthcare Professionals to Discuss Implantable Cardioverter Defibrillator Deactivation in Advanced Heart Failure: Results From an International Factorial SurveyLoreena Hill, Sonja McIlfatrick, Brian J Taylor, et al.
The Journal of Molecular Diagnostics : JMD|June 27, 2007
Microfluidic chips for detecting the t(4;14) translocation and monitoring disease during treatment using reverse transcriptase-polymerase chain reaction analysis of IgH-MMSET hybrid transcriptsJaron VanDijken, Govind V Kaigala, Jana Lauzon, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2005
SSX cancer testis antigens are expressed in most multiple myeloma patients: co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCsBrian J Taylor, Tony Reiman, Julie A Pittman, et al.
Blood|January 29, 2005
Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patientsJonathan J Keats, Christopher A Maxwell, Brian J Taylor, et al.
Malaria Journal|June 3, 2014
A lab-on-chip for malaria diagnosis and surveillanceBrian J Taylor, Anita Howell, Kimberly A Martin, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Blood|June 26, 2008
Analysis of clonotypic switch junctions reveals multiple myeloma originates from a single class switch event with ongoing mutation in the isotype-switched progenyBrian J Taylor, Jitra Kriangkum, Julie A Pittman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Molecular characterization of Waldenstrom's macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequencesJitra Kriangkum, Brian J Taylor, Steven P Treon, et al.
The American Journal of Tropical Medicine and Hygiene|July 20, 2017
A Direct from Blood Reverse Transcriptase Polymerase Chain Reaction Assay for Monitoring Falciparum Malaria Parasite Transmission in Elimination SettingsBrian J Taylor, Kjerstin Lanke, Shanna L Banman, et al.
Blood|October 24, 2002
In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expressionJonathan J Keats, Tony Reiman, Christopher A Maxwell, et al.
The Journal of Cardiovascular Nursing|May 5, 2018
Patient and Professional Factors That Impact the Perceived Likelihood and Confidence of Healthcare Professionals to Discuss Implantable Cardioverter Defibrillator Deactivation in Advanced Heart Failure: Results From an International Factorial SurveyLoreena Hill, Sonja McIlfatrick, Brian J Taylor, et al.
The Journal of Molecular Diagnostics : JMD|June 27, 2007
Microfluidic chips for detecting the t(4;14) translocation and monitoring disease during treatment using reverse transcriptase-polymerase chain reaction analysis of IgH-MMSET hybrid transcriptsJaron VanDijken, Govind V Kaigala, Jana Lauzon, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2005
SSX cancer testis antigens are expressed in most multiple myeloma patients: co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCsBrian J Taylor, Tony Reiman, Julie A Pittman, et al.
Blood|January 29, 2005
Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patientsJonathan J Keats, Christopher A Maxwell, Brian J Taylor, et al.
Malaria Journal|June 3, 2014
A lab-on-chip for malaria diagnosis and surveillanceBrian J Taylor, Anita Howell, Kimberly A Martin, et al.
Pageof 4